entertainment -WSS

entertainment

author：focus 2025-10-02 14:03:19 - browse：9231

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： AstraZeneca challenges Medicare drug negotiation program

hotspot

WSS

Biden administration opens offers in Medicare drug price negotiations

The lessons of Aduhelm, an Alzheimer's drug that was not to be

FDA panel gives mixed vote on blood pressure devices

Radiation, mainstay of cancer treatment, begins a fade

Apellis safety probe of eye disease drug centers on injection needle

2024 GOP presidential candidates spar over abortion in debate

hotspot

entertainment

hotspot

Medical leaders decry Supreme Court decision on affirmative action

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Novavax promises a turnaround & Lilly roils the obesity market

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Alkermes shareholders re

Covid misinformation case heads to Supreme Court

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Complete sequence of Y chromosome published for first time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What do new weight loss drugs mean for bariatric surgery?

leisure time

Medicare drug price negotiation’s day in court

FDA drug safety: Singulair case shows systemic surveillance flaws

Complete sequence of Y chromosome published for first time

FDA panel gives mixed vote on blood pressure devices

General Catalyst, Summa Health deal will turn on physician buy

Even great ERs can’t make up for American health disparities

leisure time

focus

hotspot

hotspot